Intelligence Driven Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
11,955
+481
+4% +$55.5K 0.25% 38
2025
Q4
$1.21M Sell
11,474
-77
-0.7% -$7.23K 0.17% 47
2025
Q3
$969K Buy
11,551
+1,615
+16% +$133K 0.13% 49
2025
Q2
$787K Sell
9,936
-1,670
-14% -$133K 0.12% 52
2025
Q1
$1.04M Sell
11,606
-1,452
-11% -$136K 0.2% 39
2024
Q4
$1.3M Buy
13,058
+1,343
+11% +$138K 0.24% 36
2024
Q3
$1.33M Buy
11,715
+5,041
+76% +$599K 0.19% 36
2024
Q2
$826K Buy
+6,674
New +$860K 0.12% 52

Other funds holding MRK

Intelligence Driven Advisers's MRK Position: Q1 2026 in Review

Intelligence Driven Advisers increased its Merck (MRK) stake by 4.2% in Q1 2026, buying an estimated $55.5K and bringing the position to 11,955 shares worth $1.44M. The position accounts for 0.25% of the portfolio, ranked #38.

Intelligence Driven Advisers first reported a position in MRK in Q2 2024 and has held it in 8 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Intelligence Driven Advisers held 11,955 shares of Merck worth $1.44M as of Q1 2026.
  • Intelligence Driven Advisers bought 481 Merck shares in Q1 2026, an estimated $55.5K.
  • Merck made up 0.25% of Intelligence Driven Advisers's portfolio in Q1 2026, its #38 holding.
  • Intelligence Driven Advisers first reported a position in Merck in Q2 2024 and has held it in 8 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Intelligence Driven Advisers's 13F filing for Q1 2026, filed 15 May 2026.